Skip to main content

APUS

Apimeds Pharmaceuticals US, Inc.

Company with tickers: APUS

CIK
1894525
CUSIP
03771D102
Shares Outstanding
15,091,177
13F Activity (30d)
3 filings 3 filers

Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.

No Exempt Offerings

No Form D exempt-offering notices are available for this stock yet.